SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000875045-20-000005
Filing Date
2020-02-06
Accepted
2020-02-06 16:32:39
Documents
190
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K biib-20191231x10k.htm   iXBRL 10-K 5818481
2 EXHIBIT 4.4 biib-20191231xex44.htm EX-4.4 129044
3 EXHIBIT 21 biib-20191231xex21.htm EX-21 63176
4 EXHIBIT 23 biib-20191231xex23.htm EX-23 2582
5 EXHIBIT 31.1 biib-20191231xex311.htm EX-31.1 13966
6 EXHIBIT 31.2 biib-20191231xex312.htm EX-31.2 14309
7 EXHIBIT 32.1 biib-20191231xex321.htm EX-32.1 6585
13 acquirediprd.jpg GRAPHIC 19652
14 amortofacquireintang.jpg GRAPHIC 20166
15 anticd20revenue.jpg GRAPHIC 46358
16 avonex.jpg GRAPHIC 5670
17 benepalia04.jpg GRAPHIC 629417
18 biogenlogo2020a01.jpg GRAPHIC 12981
19 biosimilarsrev.jpg GRAPHIC 33068
20 bubbles20192.jpg GRAPHIC 59223
21 cogs.jpg GRAPHIC 32717
22 collaborationprofitshare.jpg GRAPHIC 20088
23 equityinlossofinvestee.jpg GRAPHIC 17223
24 fampyra.jpg GRAPHIC 2031
25 finhighlights.jpg GRAPHIC 35555
26 flixabi.jpg GRAPHIC 628388
27 fumaderm.jpg GRAPHIC 3140
28 fvremeasurementcc.jpg GRAPHIC 19677
29 gazyva.jpg GRAPHIC 21759
30 imraldi.jpg GRAPHIC 629442
31 incometaxprovision.jpg GRAPHIC 35034
32 interferonrev.jpg GRAPHIC 35937
33 lossondivestitureofdenmark.jpg GRAPHIC 18380
34 marketedproductsrev.jpg GRAPHIC 86887
35 nci.jpg GRAPHIC 17897
36 ocrevus.jpg GRAPHIC 30240
37 otherincomeexpense.jpg GRAPHIC 18245
38 otherrev.jpg GRAPHIC 29530
39 plegridy.jpg GRAPHIC 5127
40 researchanddev.jpg GRAPHIC 39169
41 researchanddevelopment.jpg GRAPHIC 69143
42 reservesdisandallow.jpg GRAPHIC 32711
43 rituxan.jpg GRAPHIC 9985
44 rituxanhycelalogo300x87.jpg GRAPHIC 9120
45 sellinggeneralandadmin.jpg GRAPHIC 20785
46 spinrazalogonewa01.jpg GRAPHIC 72059
47 spinrazarev.jpg GRAPHIC 34301
48 stockperfgraph.jpg GRAPHIC 66807
49 tecfidera.jpg GRAPHIC 7384
50 tecfiderarev.jpg GRAPHIC 35617
51 tysabri.jpg GRAPHIC 6359
52 tysabrirev.jpg GRAPHIC 36569
53 vumerity-logoa03.jpg GRAPHIC 4657
  Complete submission text file 0000875045-20-000005.txt   33018966

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT biib-20191231.xsd EX-101.SCH 129843
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT biib-20191231_cal.xml EX-101.CAL 165403
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT biib-20191231_def.xml EX-101.DEF 852984
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT biib-20191231_lab.xml EX-101.LAB 1694809
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT biib-20191231_pre.xml EX-101.PRE 1196746
88 EXTRACTED XBRL INSTANCE DOCUMENT biib-20191231x10k_htm.xml XML 5597943
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19311 | Film No.: 20583107
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences